Robert brings 25 years of life science capital market and corporate counsel experience. He founded the Company, and has served as Chairman and Chief Executive. Aurora Biopharma is a private biopharmaceutical company that was formed to research and develop autologous CAR T Cell Therapy targeting HER2 expression in solid tumors. He is the CEO of Alphageneron Pharmaceuticals dedicated to immune cell therapy for cancer. Prior to Aurora, Robert founded and served as Chief Executive Officer of Medvax Technologies, a clinical stage cancer immunotherapy company developing dendritic cell and peptide cancer vaccines. Robert is also the Founder, Chairman & Chief Executive Officer of Metabogenix Technologies.

Metabogenix Technologies, Inc. is a private biotechnology company developing small molecules that disrupt the metabolism of cancer cells. Robert has been corporate counsel to numerous life science companies. He has participated in over $500 million of private and public offerings of life science and growth companies in the capital markets. Robert has also been the managing partner at Law Offices of Robert Brooks. He serves on the board of several cancer gene therapy biotechnology companies.

He received his B.S. in Biology (pre-medicine concentration) Cum Laude from the University of Massachusetts, and Juris Doctorate from the University of Miami Law School. He has held a Series 7 securities license.